OakChart

Nautilus Biotechnology Inc

NAUTHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 10:00 AM ET

2.51+0.19 (7.97%)
2026-11-11 16:00 CET
Market cap
295.50 USD m
Revenue, TTM
0.42 USD m
Net income, TTM
-58.58 USD m
Free cash flow, TTM
-55.13 USD m
EPS diluted, TTM
-0.46
P/E
-
Compare

Price

NAUT against its 20, 50 and 200-day averages
2050200beat
1.002.003.0014.8M29.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NAUTclose 2.5120-day 2.5550-day 1.82200-day 2.132.51

41.9% under 4.31 on 25 Mar 2026. Last 15 sessions, 71.9% high to low

Profile

NAUT
52-week range, 48% of the way up
0.844.31

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

IndexRUT
Employees130
IPOAug 07, 2020
Beta0.68
ATR, 14d0.35
Rel volume1.16
Short float7.90%
Insider own41.98%
Inst own27.58%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap319.06M
Enterprise Value259.22M
Income-58.58M
Sales0.42M
Book/sh0.92
Cash/sh0.68
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees130
IPOAug 07, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S759.68
P/B2.74
P/C3.69
P/FCF-
EV/EBITDA-
EV/Sales617.20
Quick Ratio9.25
Current Ratio9.25
Debt/Eq0.23
LT Debt/Eq0.19
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.46
EPS next Y-0.48
EPS next Q-0.14
EPS this Y-3.19%
EPS next Y0.00%
EPS next 5Y1.68%
EPS past 3/5Y-0.17% 0.21%
Sales past 3/5Y- -
EPS Y/Y TTM7.31%
Sales Y/Y TTM-
EPS Q/Q-14.33%
Sales Q/Q-
EarningsOct 27 BMO
EPS/Sales Surpr.14.29% 13.43%

Ownership

Insider Own41.98%
Insider Trans-8.55%
Inst Own27.58%
Inst Trans-4.85%
ROA-33.49%
ROE-41.01%
ROIC-42.10%
Gross Margin-1242.22%
Oper. Margin-15105.66%
Profit Margin-13816.75%
SMA20-1.61%
SMA5037.93%
SMA20017.79%
Trades-

Technical

Shs Outstand127.33M
Shs Float73.90M
Short Float7.90%
Short Ratio1.02
Short Interest5.84M
52W High4.31 -41.88%
52W Low0.84 197.82%
Volatility11.19% 18.08%
ATR (14)0.35
RSI (14)54.27
Beta0.68
Rel Volume1.16
Avg Volume5.75M
Volume824,453

Performance

Perf Week9.39%
Perf Month22.20%
Perf Quarter181.46%
Perf Half Y-15.08%
Perf YTD28.46%
Perf Year50.90%
Perf 3Y-5.47%
Perf 5Y-51.83%
Perf 10Y-
Recom1.00
Target Price4.00
Prev Close2.32
Price2.51
Change %7.97%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
Sep 29, 2026InitiatedRRoth CapitalBuy$3.50+39.7%
Sep 09, 2026InitiatedLLeerink PartnersOutperform$4+59.7%
Dec 05, 2024DowngradeGGoldmanNeutral → Sell$1.75-30.1%
Jun 27, 2024InitiatedGGuggenheimBuy$6+139.5%
Jun 03, 2024ResumedJJefferiesHold$3+19.8%
Jan 06, 2022InitiatedMMorgan StanleyEqual-Weight$8+219.4%
Nov 02, 2021InitiatedCCowenOutperform
Aug 04, 2021InitiatedGGoldmanNeutral$10+299.2%
Jul 13, 2021InitiatedJJefferiesBuy$13+419.0%

Peers

Mkt cap
TickerCompanyMkt cap
SEERSeer Inc89.70M
QSIQuantum-Si Incorporated289.95M
QTRXQuanterix Corp159.53M
LABStandard BioTools Inc271.30M
TWSTTwist Bioscience Corp9.09B
ABSIAbsci Corp1.71B
CDXSCodexis Inc107.04M
PACBPacific Biosciences of California Inc705.65M
TXG10x Genomics Inc8.46B
TECHBio-Techne Corp11.44B

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
AH Equity Partners Bio II, L.L10% OwnerJun 02 '26Sale2.355,000,00011,750,000971,885Jun 04 04:53 PM
Patel Sujal MCEO, President, and SecretaryMar 04 '26Buy2.6125,00065,23810,366,721Mar 04 06:37 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWVVanguard Russell 2000 Value Index ETFAUM: 1.29B
RSSLGlobal X Russell 2000 ETFAUM: 1.43B

News

latest 14 of 206
  • Nautilus Beats On A Narrower-Than-Expected Loss, But Rising Spending And A Looming Raise Shadow Strong Proteoform Data (Earnings Whispers) +18.44%
  • Nautilus to Measure Proteoforms Driving Alzheimer's Disease and Cancer in ARPA-H-Funded SEEDS Consortium (GlobeNewswire)
  • Nautilus Biotechnology Reports Third Quarter 2026 Financial Results (GlobeNewswire)
  • Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026 (GlobeNewswire)
  • Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms (GlobeNewswire)
  • Loading…
  • Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ... (GuruFocus.com) -27.71% -13.33%
  • Nautilus Biotechnology Reports Second Quarter 2026 Financial Results (GlobeNewswire)
  • Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 (GlobeNewswire) +5.33%
  • Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
  • Nautilus Biotechnology Reports First Quarter 2026 Financial Results (GlobeNewswire)
  • Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 (GlobeNewswire)
  • Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference (GlobeNewswire) +9.12%
  • Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-27-0.120-0.140-0.1200.230.214
2026Q22026-07-28-0.110-0.135-0.1140.190.002
2026Q12026-04-28-0.120-0.145-0.1160.000.002
2025Q42026-02-26-0.110-0.140-0.1090.000.002
2025Q32025-10-28-0.110-0.150-0.1080.000.002
2025Q22025-07-31-0.120-0.155-0.1190.000.002
2025Q12025-04-29-0.130-0.146-0.1320.000.005
2024Q42025-02-27-0.140-0.153-0.1400.000.005
2024Q32024-10-29-0.130-0.165-0.1310.000.004
2024Q22024-07-30-0.140-0.164-0.1440.000.005
2024Q12024-04-30-0.150-0.163-0.1500.000.004
2023Q42024-02-28-0.140-0.158-0.1360.000.004
2023Q32023-10-31-0.130-0.155-0.1270.000.004
2023Q22023-08-02-0.130-0.150-0.1270.000.004
2023Q12023-05-02-0.120-0.163-0.1200.000.004
2022Q42023-02-23-0.110-0.153-0.1070.000.004

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-0.600-0.585-0.5960.000.00
2022FY-0.460-0.513-0.4650.000.00
2023FY-0.510-0.558-0.5100.000.00
2024FY-0.560-0.600-0.5640.000.00
2025FY-0.470-0.525-0.4700.000.00
2026FY--0.485--0.67
2027FY--0.485--5.77
2028FY--0.447--17.95
2029FY--0.397--39.46
2030FY--0.317--74.90

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-274300.260.200.30
2026Q4S2026-10-114000.210.200.23
2026Q4S2026-09-284020.210.200.23
2026Q4S2026-09-083020.210.200.23
2026Q4S2026-07-282020.200.200.20
2026Q4S2026-05-122000.600.500.70
2026Q4S2026-04-282110.600.500.70
2026Q4S2026-02-262110.600.500.70
2026Q4S2026-01-112001.500.003.00
2026Q4S2025-11-112011.500.003.00
2026Q4S2025-11-102011.500.003.00
2026Q4S2025-11-092011.500.003.00
2026Q4S2025-11-082011.500.003.00
2026Q4S2025-11-072011.500.003.00

Estimate history

EPS, annual-0.472-0.596-0.465-0.51-0.564-0.467-0.4618
Period202020212022202320242025TTM
EPS, quarterly-0.131-0.14-0.132-0.119-0.108-0.109-0.116-0.114-0.123
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0000000.42
Period202020212022202320242025TTM
Sales, quarterly00000000.190.234
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual33.07124.303124.865125.069126.106126.47127.329
Period202020212022202320242025MRQ
Shares, quarterly125.56126.106126.148126.305126.305126.47127.07127.225127.329
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue0.420.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A5.696.466.355.713.422.842.35
Gross Profit-5.27-6.46-6.35-5.71-3.42-2.84-2.35
Selling, General and Administrative Excl. Other58.7860.3775.1270.4560.2047.6613.40
Research and Development37.7839.3648.5045.4036.4526.5110.09
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-64.05-66.84-81.48-76.15-63.62-50.50-15.74
Interest Expense0.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.00
Net Income Before Taxes-58.58-59.00-70.78-63.67-57.92-50.31-15.62
Income Taxes0.000.000.000.000.000.000.00
Consolidated Net Income-58.58-59.00-70.78-63.67-57.92-50.31-15.62
Net Income From Continuing Operations-58.58-59.00-70.78-63.67-57.92-50.31-15.62
Net Income-58.58-59.00-70.78-63.67-57.92-50.31-15.62
EPS (Recurring)-0.46-0.47-0.56-0.51-0.46-0.60-0.47
EPS (Basic, Before Extraordinaries)-0.46-0.47-0.56-0.51-0.46-0.60-0.47
EPS (Diluted)-0.46-0.47-0.56-0.51-0.46-0.60-0.47
EBITDA-58.40-60.37-75.12-70.45-60.20-47.66-13.40
Non-Operating Income (Expense)5.467.8410.7012.485.690.180.12
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense5.286.8412.7012.1410.387.930.37
Price To Sales Ratio426.13------
Gross Margin-1,242.22------
Operating Margin-15,105.66------
Net Margin-13,816.75------
Shares Outstanding127.33126.47126.11125.07124.87124.3033.07
Market Capitalization295.50295.50210.95373.59224.50643.19664.29

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.230.190.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A1.331.301.481.591.621.631.626.35
Gross Profit-1.09-1.11-1.48-1.59-1.62-1.63-1.62-6.35
Selling, General and Administrative Excl. Other15.6414.6514.6513.8413.8515.4617.2213.63
Research and Development9.909.349.379.179.189.9411.0710.85
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-16.74-15.76-16.12-15.42-15.47-17.10-18.84-19.98
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-15.64-14.47-14.70-13.78-13.57-15.03-16.61-17.59
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-15.64-14.47-14.70-13.78-13.57-15.03-16.61-17.59
Net Income From Continuing Operations-15.64-14.47-14.70-13.78-13.57-15.03-16.61-17.59
Net Income-15.64-14.47-14.70-13.78-13.57-15.03-16.61-17.59
EPS (Recurring)-0.12-0.11-0.12-0.11-0.11-0.12-0.13-0.14
EPS (Basic, Before Extraordinaries)-0.12-0.11-0.12-0.11-0.11-0.12-0.13-0.14
EPS (Diluted)-0.12-0.11-0.12-0.11-0.11-0.12-0.13-0.14
EBITDA-15.43-14.48-14.65-13.84-13.85-15.46-17.22-13.63
Non-Operating Income (Expense)1.101.291.431.641.902.062.232.39
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.291.161.361.471.501.712.173.12
Price To Sales Ratio426.131,251.28------
Gross Margin-467.52-583.68------
Operating Margin-7,152.56-8,296.32------
Net Margin-6,682.05-7,615.26------
Shares Outstanding127.33127.22127.07126.47126.31126.31126.15126.11
Market Capitalization295.50237.64491.07246.29106.7291.44108.61210.95

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments103.41129.89173.42184.47345.7376.74
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets2.562.933.422.743.490.92
Total Current Assets105.96132.83176.84187.21349.2277.66
Net Property, Plant & Equipment31.2332.3336.9032.5731.866.21
Total Investments and Advances53.7477.4191.65130.1217.210.61
Intangible Assets---0.000.000.00
Other Assets0.180.180.180.150.150.53
Total Assets191.11242.74305.56350.05398.4585.01
Short Term Debt Incl. Current Port. of LT Debt3.834.103.541.990.971.48
Accounts Payable0.940.991.641.271.720.00
Other Current Liabilities3.182.553.943.533.121.54
Total Current Liabilities7.957.639.126.795.813.02
Long Term Debt26.1926.3831.0928.3429.06111.71
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities34.1434.0140.2135.1334.87114.73
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity156.97208.73265.35314.92363.58-29.72
Total Shareholders Equity156.97208.73265.35314.92363.58-29.72
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity156.97208.73265.35314.92363.58-29.72
Total Liabilities & Stockholders Equity191.11242.74305.56350.05398.4585.01
Book Value Per Share1.241.662.122.522.92-0.90
Tangible Book Value Per Share1.241.662.122.522.92-0.90
Full-Time Employees130155167134113-
Price to Book Ratio2.530.941.350.691.771.76
Return on Assets-27.20-25.82-19.42-15.48-18.32-
Return on Equity-32.27-29.86-21.95-17.07-19.78-
Return on Invested Capital-32.21-30.10-21.48-16.87-12.81-19.05
Quick Ratio13.3317.4019.3927.5760.0925.73
Current Ratio13.3317.4019.3927.5760.0925.73

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-58.58-59.00-70.78-63.67-57.92-50.31-15.62
Depreciation5.656.466.355.713.422.842.35
Other Funds (Non Cash)5.115.4210.749.489.498.250.66
Funds from Operations-47.82-47.11-53.69-48.49-45.02-39.22-12.61
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-4.66-3.58-5.46-3.22-0.79-0.02-1.39
Cash from Operating Activities-52.48-50.70-59.15-51.71-45.81-39.24-14.00
Capital Expenditures-2.65-1.28-2.12-2.44-2.32-2.27-0.92
Net Assets From Acquisitions0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.00
Purchase or Sale of Investments40.1336.5069.13-41.29-23.42-136.69-24.36
Purchase of Investments-71.21-72.49-86.28-112.89-186.59-221.79-68.36
Sale Or Maturity of Investments111.35108.99155.4171.60163.1885.1044.00
Other Uses0.000.00-0.760.000.000.000.00
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities37.4835.2266.25-43.73-25.74-138.96-25.28
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock1.480.211.140.370.56-7.9675.90
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock1.480.211.140.370.56-7.9675.90
Proceedsfrom Stock Options0.160.160.520.260.23-8.1375.86
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.00335.410.00
Other Financing Activities Uses0.000.000.000.000.000.000.00
Cash from Financing Activities1.480.211.140.370.56327.4575.90
Net Change in Cash-13.53-15.268.25-95.08-70.98149.2436.62
Free Cash Flow-55.13-51.97-61.27-54.15-48.13-41.51-14.92
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments86.5884.0395.87103.41131.43147.87
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets3.663.602.962.562.902.85
Total Current Assets90.2487.6398.83105.96134.32150.72
Net Property, Plant & Equipment29.8629.6230.2731.2328.3529.65
Total Investments and Advances28.6546.1648.5153.7438.0632.64
Other Assets0.180.170.170.180.180.18
Total Assets148.92163.58177.78191.11200.91213.19
Short Term Debt Incl. Current Port. of LT Debt4.133.993.853.834.214.22
Accounts Payable1.261.091.190.940.890.97
Other Current Liabilities4.363.553.313.183.882.94
Total Current Liabilities9.768.648.347.958.988.14
Long Term Debt22.6123.8225.0226.1922.7923.96
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities32.3732.4633.3634.1431.7832.09
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity116.56131.11144.41156.97169.14181.09
Total Shareholders Equity116.56131.11144.41156.97169.14181.09
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity116.56131.11144.41156.97169.14181.09
Total Liabilities & Stockholders Equity148.92163.58177.78191.11200.91213.19
Book Value Per Share0.921.031.141.241.341.43
Tangible Book Value Per Share0.921.031.141.241.341.43
Full-Time Employees---130--
Price to Book Ratio2.531.653.131.460.590.47
Return on Assets-33.49-30.00-28.16-27.20-27.27-27.03
Return on Equity-41.01-36.21-33.69-32.27-32.00-31.55
Return on Invested Capital-11.24-9.34-8.67-7.52-7.07-7.33
Quick Ratio9.2510.1411.8513.3314.9518.52
Current Ratio9.2510.1411.8513.3314.9518.52

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-15.64-14.47-14.70-13.78-13.57-15.03
Depreciation1.301.281.481.591.621.63
Other Funds (Non Cash)1.311.171.291.341.191.27
Funds from Operations-13.02-12.02-11.93-10.86-10.77-12.13
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.26-1.71-1.17-1.52-0.27-1.22
Cash from Operating Activities-13.28-13.73-13.10-12.38-11.03-13.35
Capital Expenditures-1.45-0.45-0.51-0.24-0.42-0.40
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments11.8812.4814.741.030.8714.87
Purchase of Investments-9.00-17.43-11.06-33.72-27.49-4.38
Sale Or Maturity of Investments20.8829.9125.8034.7528.3619.25
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities10.4412.0214.230.790.4514.47
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.030.241.100.100.000.10
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.030.241.100.100.000.10
Proceedsfrom Stock Options0.000.000.000.160.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.030.241.100.100.000.10
Net Change in Cash-2.82-1.462.24-11.49-10.581.22
Free Cash Flow-14.73-14.18-13.61-12.62-11.45-13.75

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.90%5.8M73.9M5.28M
2026-10-157.61%5.6M73.8M3.45M
2026-09-307.82%5.8M73.8M1.49M
2026-09-156.02%4.1M67.8M1.00M
2026-08-315.74%3.8M66.4M858.72K
2026-08-145.59%3.2M56.4M835.64K
2026-07-313.58%2.3M63.5M759.89K
2026-07-152.29%1.4M63.4M659.62K
2026-06-301.31%0.8M63.4M526.42K
2026-06-150.91%0.5M59.8M396.83K
2026-05-291.40%0.8M54.5M360.86K
2026-05-151.36%0.8M60.5M340.53K
2026-04-301.18%0.7M60.5M301.08K
2026-04-151.06%0.6M60.3M286.03K
2026-03-311.12%0.7M60.2M272.24K
2026-03-130.74%0.4M60.2M214.64K
2026-02-270.65%0.4M60.2M223.99K
2026-02-130.57%0.3M60.1M246.02K
2026-01-300.51%0.3M60.1M325.27K
2026-01-150.61%0.4M60.1M451.36K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.501.502.252.0014.6782.000.000.972-0.0230.000
call1.001.001.751.158.5211520.000.911-0.0310.001
call1.500.501.251.805.49673.000.000.843-0.0300.001
call2.000.100.800.303.8466580.000.744-0.0250.001
call2.500.100.250.121.6203,3240.000.587-0.0240.002
call5.000.000.050.053.1221,2180.000.107-0.0110.001
call7.500.000.750.014.1452560.000.086-0.0140.001
put0.500.000.750.0016.1790.000.00-0.028-0.0230.000
put1.000.000.750.078.8551.000.00-0.089-0.0310.001
put1.500.000.750.015.72517.000.00-0.157-0.0290.001
put2.000.000.300.053.6641,7360.00-0.251-0.0250.001
put2.500.200.650.254.1902,04620.00-0.413-0.0240.002
put5.002.253.002.456.4766.000.00-0.893-0.0110.001
put7.504.605.600.008.4130.000.00-0.914-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-03SCHEDULE 13D/ASEC
2026-10-2710-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-09-18EFFECTEffectiveness filing by commission orderSEC
2026-09-18424B5SEC
2026-09-118-KCurrent report2026-09-11SEC
2026-09-11S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-09-11SCHEDULE 13D/ASEC
2026-08-28SCHEDULE 13D/ASEC
2026-08-14SCHEDULE 13D/ASEC
2026-07-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-06-30SCHEDULE 13D/ASEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-188-KCurrent report2026-06-17SEC
2026-06-04SCHEDULE 13D/ASEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-04-28ARSAnnual report to security holders. 2025-12-31SEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-17SEC
2026-04-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-288-KCurrent report2026-04-28SEC
2026-03-044Statement of changes in beneficial ownership of securities2026-03-02SEC
2026-03-044Statement of changes in beneficial ownership of securities2026-03-02SEC
2026-03-04SCHEDULE 13D/ASEC
2026-03-044Statement of changes in beneficial ownership of securities2026-03-02SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060011.75M1
2026-050000
2026-040000
2026-0365.24K100
2026-020000
2026-010000
2025-120000
2025-115.96K100

Institutional holders

Manager% owned
PERCEPTIVE ADVISORS LLC9.16%
a16z Capital Management, L.L.C.7.13%
Cercano Management LLC5.64%
BlackRock, Inc.2.11%
VANGUARD CAPITAL MANAGEMENT LLC2.01%
Comprehensive Financial Management LLC1.74%
ACADIAN ASSET MANAGEMENT LLC1.67%
CITADEL ADVISORS LLC1.49%
GEODE CAPITAL MANAGEMENT, LLC1.10%
Clearstead Advisors, LLC0.70%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.52%
iShares Russell 2000 ETF0.84%
VANGUARD EXTENDED MARKET INDEX FUND0.43%
Fidelity Small Cap Index Fund0.43%
iShares Russell 2000 Value ETF0.30%
JPMorgan Small Cap Value Fund0.26%
VANGUARD RUSSELL 2000 INDEX FUND0.23%
iShares Micro-Cap ETF0.13%
Ultra-Small Company Market Fund0.10%
Small Cap Value Fund0.10%

OakChart. NAUT. Cached 15 minutes.